Lateral Flow Assays Market Report 2026

Lateral Flow Assays Market Overview

• Lateral Flow Assays market size has reached to $12.29 billion in 2025 • Expected to grow to $19.3 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Surge In Infectious Diseases Drives Expansion Of Lateral Flow Assay Market • Market Trend: Portable Lateral Flow Reader For On-The-Go Testing In Food And Environmental Settings • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lateral Flow Assays Market?

A lateral flow assay (LFA) is made up of four parts: a sample pad where the sample is dropped, a conjugate pad where labelled tags and biorecognition elements are combined, a reaction membrane with test and control lines for target antigen-antibody interaction, and an absorbent pad where waste is stored. The main types of lateral flow assay are kits and reagents, and lateral flow readers. The lateral flow readers refer to instruments used to read and analyze the findings of lateral flow tests. The lateral flow assay works on sandwich assays, competitive assays, and multiplex detection assays techniques. These are used for veterinary diagnostics, clinical/point-of-care testing, drug development and quality testing, and other applications by hospitals and clinics, diagnostic laboratories, home care settings, pharmaceutical and biotechnology companies, and other end users.

What Is The Lateral Flow Assays Market Growth Forecast?

The lateral flow assays market size is expected to see strong growth in the next few years. It will grow to $19.3 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing adoption of home-based diagnostics, expansion of digital health integration, growing demand for multiplex testing, rising investments in rapid diagnostic technologies, increasing focus on real-time disease monitoring. Major trends in the forecast period include increasing adoption of rapid point-of-care diagnostics, rising use of multiplex lateral flow assays, growing integration of digital lfa readers, expansion of veterinary and home-based testing, enhanced focus on test sensitivity.

Global Lateral Flow Assays Market Segmentation

1) By Type: Kits And Reagents, Lateral Flow Readers 2) By Technique: Sandwich Assays, Competitive Assays, Multiplex Detection Assays 3) By Application: Veterinary Diagnostics, Clinical Or Point-Of-Care Testing, Drug Development And Quality Testing, Other Applications 4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Home Care Settings, Pharmaceutical And Biotechnology Companies, Other End Users Subsegments: 1) By Kits And Reagents: Rapid Test Kits, Diagnostic Kits, Control Reagents, Sample Collection And Preparation Reagents 2) By Lateral Flow Readers: Portable Lateral Flow Readers, Benchtop Lateral Flow Readers, Smartphone-Based Lateral Flow Readers, Automated Lateral Flow Readers

What Is The Driver Of The Lateral Flow Assays Market?

The high prevalence of infectious diseases across the globe significantly contributes to the growth of the lateral flow assay market. In developing countries, the high frequency of infectious diseases such as HIV and malaria, combined with the inadequate healthcare system and rising public awareness, is projected to accelerate the adoption of lateral flow assay testing. The recent COVID-19 pandemic has highlighted the need for early illness detection capabilities, projected to fuel market expansion. For instance, in August 2024, according to the data published by the UK Health Security Agency, a UK-based executive agency, in England, the UK Health Security Agency (UKHSA) reported 368 measles cases in 2023, marking a nearly sevenfold increase from the 53 cases reported in 2022, with the West Midlands and London accounting for 44% and 33% of the cases, respectively. Therefore, the high prevalence of infectious diseases across the globe will contribute to the growth of the lateral flow assay industry.

Key Players In The Global Lateral Flow Assays Market

Major companies operating in the lateral flow assays market are Siemens AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Hologic Inc., BioMérieux SA, PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Roche Holding AG, QIAGEN N.V., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Molbio Diagnostics, Trinity Biotech, Chembio Diagnostics Inc., Coris BioConcept, HYCOR Biomedical, Diagnostic BioSystems GmbH, Express Diagnostics Ltd., Fujirebio Diagnostics Inc., Innova Diagnostics Inc., Leadtec Diagnostics Inc., S&D Diagnostics Inc., Standard Diagnostics Inc., V-Chek Diagnostics

Global Lateral Flow Assays Market Trends and Insights

Major companies in the lateral flow assay market are focused on developing versatile products, such as lateral flow readers, for providing on-the-go testing and to gain a competitive edge in the market. A lateral flow reader is a portable device used for quick and qualitative analysis of lateral flow assays, providing efficient results in various testing environments. For instance, in February 2024, Upfront Diagnostics, a UK-based healthcare company, launched the Lateral Flow Test for Triaging Stroke Patients Next Year. designed specifically for triaging stroke patients, this test, known as LVOne, aims to significantly enhance the speed and accuracy of stroke diagnosis in pre-hospital settings. The LVOne test is a rapid blood test that allows paramedics to identify strokes caused by large vessel occlusions (LVO) within 15 minutes. This quick identification is crucial for fast-tracking patients to specialized stroke centers where timely treatment can drastically improve outcomes and reduce long-term disabilities.

What Are Latest Mergers And Acquisitions In The Lateral Flow Assays Market?

In December 2023, Danaher Corporation, a US-based software company, acquired Abcam plc for an undisclosed amount. This acquisition was aimed at strengthening Danaher Corporation's portfolio and market position, enhancing its presence in the life sciences and diagnostics industry. Abcam plc is a UK-based producer, distributor, and seller of protein research tools and universal lateral flow assay kits.

Regional Outlook

North America was the largest region in the lateral flow assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the lateral flow assays market share during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Lateral Flow Assays Market?

The lateral flow assay market consists of the sale of kits, reagents, and assemblies. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this lateral flow assay market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.